Jing Cheng et al. observed that solafenib increased cell viability by reducing siRNA-mediated ACSL4 silencing, suggesting that ACSL4 may protect glioma cells and inhibit their proliferation via activating a ferroptosis pathway [16]. This evidence concerns the gene ACSL4 and central nervous system cancer.